Literature DB >> 31383654

Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.

Jie Lin1, Chunquan Xu1, Renchi Fang1, Jianming Cao2, Xiucai Zhang1, Yajie Zhao3, Guofeng Dong3, Yao Sun1, Tieli Zhou4.   

Abstract

The goal was to investigate the mechanisms of colistin resistance and heteroresistance in Pseudomonas aeruginosa clinical isolates. Colistin resistance was determined by the broth microdilution method. Colistin heteroresistance was evaluated by population analysis profiling. Time-kill assays were also conducted. PCR sequencing was performed to detect the resistance genes among (hetero)resistant isolates, and quantitative real-time PCR assays were performed to determine their expression levels. Pulsed-field gel electrophoresis and multilocus sequence typing were performed. Lipid A characteristics were determined via matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS). Two resistant isolates and 9 heteroresistant isolates were selected in this study. Substitutions in PmrB were detected in 2 resistant isolates. Among heteroresistant isolates, 8 of 9 heteroresistant isolates had nonsynonymous PmrB substitutions, and 2 isolates, including 1 with a PmrB substitution, had PhoQ alterations. Correspondingly, the expression levels of pmrA or phoP were upregulated in PmrB- or PhoQ-substituted isolates. One isolate also found alterations in ParRS and CprRS. The transcript levels of the pmrH gene were observed to increase across all investigated isolates. MALDI-TOF MS showed additional 4-amino-4-deoxy-l-arabinose (l-Ara4N) moieties in lipid A profiles in (hetero)resistant isolates. In conclusion, both colistin resistance and heteroresistance in P. aeruginosa in this study mainly involved alterations of the PmrAB regulatory system. There were strong associations between mutations in specific genetic loci for lipid A synthesis and regulation of modifications to lipid A. The transition of colistin heteroresistance to resistance should be addressed in future clinical surveillance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosazzm321990; colistin; heteroresistance; lipid A modification; molecular mechanisms; resistance

Year:  2019        PMID: 31383654      PMCID: PMC6761505          DOI: 10.1128/AAC.00556-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.

Authors:  Jian Li; Craig R Rayner; Roger L Nation; Roxanne J Owen; Denis Spelman; Kar Eng Tan; Lisa Liolios
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Mode of action of streptomycin on type B Hemophilus influenzae.

Authors:  H E ALEXANDER
Journal:  Am J Dis Child       Date:  1948-03

3.  Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system.

Authors:  Emily M Nowicki; John P O'Brien; Jennifer S Brodbelt; M Stephen Trent
Journal:  Mol Microbiol       Date:  2015-05-09       Impact factor: 3.501

4.  The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification.

Authors:  Hervé Nicoloff; Karin Hjort; Bruce R Levin; Dan I Andersson
Journal:  Nat Microbiol       Date:  2019-02-11       Impact factor: 17.745

5.  Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula.

Authors:  Phillip J Bergen; Alan Forrest; Jürgen B Bulitta; Brian T Tsuji; Hanna E Sidjabat; David L Paterson; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A.

Authors:  Samuel M Moskowitz; Robert K Ernst; Samuel I Miller
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

8.  The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.

Authors:  Jacob R Chambers; Karin Sauer
Journal:  J Bacteriol       Date:  2013-08-09       Impact factor: 3.490

9.  Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test.

Authors:  Laurent Dortet; Remy A Bonnin; Ivana Pennisi; Lauraine Gauthier; Agnès B Jousset; Laura Dabos; R Christopher D Furniss; Despoina A I Mavridou; Pierre Bogaerts; Youri Glupczynski; Anais Potron; Patrick Plesiat; Racha Beyrouthy; Frédéric Robin; Richard Bonnet; Thierry Naas; Alain Filloux; Gerald Larrouy-Maumus
Journal:  J Antimicrob Chemother       Date:  2018-12-01       Impact factor: 5.790

10.  Identification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids.

Authors:  Lisa M Leung; William E Fondrie; Yohei Doi; J Kristie Johnson; Dudley K Strickland; Robert K Ernst; David R Goodlett
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

View more
  16 in total

1.  Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.

Authors:  Shihui Yu; Xiaohui Pu; Maizbha Uddin Ahmed; Heidi H Yu; Tarun Tejasvi Mutukuri; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-10-06       Impact factor: 5.875

Review 2.  Causes of polymyxin treatment failure and new derivatives to fill the gap.

Authors:  Selena Chiu; Anna M Hancock; Bob W Schofner; Katherine J Sniezek; Nashaly Soto-Echevarria; Gabrielle Leon; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2022-09-20       Impact factor: 3.424

3.  Prevalence and Molecular Characteristics of Polymyxin-Resistant Pseudomonas aeruginosa in a Chinese Tertiary Teaching Hospital.

Authors:  Chenlu Xiao; Yan Zhu; Zhitao Yang; Dake Shi; Yuxing Ni; Li Hua; Jian Li
Journal:  Antibiotics (Basel)       Date:  2022-06-14

4.  Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.

Authors:  Jessica Howard-Anderson; Michelle Davis; Alexander M Page; Chris W Bower; Gillian Smith; Jesse T Jacob; Dan I Andersson; David S Weiss; Sarah W Satola
Journal:  J Antimicrob Chemother       Date:  2022-02-23       Impact factor: 5.758

5.  Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China.

Authors:  Wenli Liao; Jie Lin; Huaiyu Jia; Cui Zhou; Ying Zhang; Yishuai Lin; Jianzhong Ye; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-10-09       Impact factor: 4.003

Review 6.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa.

Authors:  Ye Xu; Xiangkuo Zheng; Weiliang Zeng; Tao Chen; Wenli Liao; Jiao Qian; Jie Lin; Cui Zhou; Xuebin Tian; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-05-14       Impact factor: 4.003

8.  Evaluation of resazurin-based assay for rapid detection of polymyxin-resistant gram-negative bacteria.

Authors:  Huaiyu Jia; Renchi Fang; Jie Lin; Xuebin Tian; Yajie Zhao; Lijiang Chen; Jianming Cao; Tieli Zhou
Journal:  BMC Microbiol       Date:  2020-01-08       Impact factor: 3.605

Review 9.  It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Payam Behzadi; Zoltán Baráth; Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2021-01-04

10.  In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori.

Authors:  Maciej Spiegel; Paweł Krzyżek; Ewa Dworniczek; Ryszard Adamski; Zbigniew Sroka
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.